John Shannon
President at XERIS BIOPHARMA HOLDINGS, INC.
Net worth: 941 275 $ as of 2024-04-29
Profile
Mr. John P.
Shannon, Jr., is a President & Chief Operating Officer at Xeris Biopharma Holdings, Inc. Mr. Shannon was previously employed as a President, Chief Operating Officer & Director by Xeris Pharmaceuticals, Inc., a Chief Executive Officer & Director by Catheter Connections, Inc., a Chief Commercial Officer by Durata Therapeutics, Inc., a Vice President & General Manager by Baxter BioScience Corp., a General Manager-US Biopharmaceuticals by Baxter Healthcare Corp., a Senior Director by Viatris Holdings LLC, a Head-Sales Operations, Marketing & Strategic by Bock Pharmacal Co., and a Vice President-Marketing by Caremark LLC.
He received his undergraduate degree from Western Illinois University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-11 | 553,691 ( 0.37% ) | 941 275 $ | 2024-04-29 |
John Shannon active positions
| Companies | Position | Start |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | President | 2021-10-04 |
Former positions of John Shannon
| Companies | Position | End |
|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Chief Executive Officer | 2015-12-31 |
| DURATA THERAPEUTICS INC | Corporate Officer/Principal | 2014-10-31 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | 2011-12-31 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2010-12-31 |
| Viatris Holdings LLC | Corporate Officer/Principal | 2000-12-31 |
Training of John Shannon
| Western Illinois University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Bock Pharmacal Co.
 Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Bock Pharmacal Co. is a wholesale pharmaceutical packaging and distribution company. The company is based in St. Louis, MO. Bock Pharmacal was acquired by Sanofi on July 17, 1996. | Commercial Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
| Viatris Holdings LLC | |
| Caremark LLC | |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- John Shannon
